NUZ — Neurizon Therapeutics Share News
0.000.00%
Last trade - 00:00- AU$33.22m
- AU$26.89m
Brief: Pharmaust Seeks Trading Halt
Brief: Pharmaust Says Epichem Enters Voluntary Liquidation
Brief: Pharmaust Seeks Trading Halt
Brief: Pharmaust Seeks Trading Halt
Australia's Pharmaust rises on progress on Motor Neurone Disease drug trial
Brief: Pharmaust Ltd Seeks Trading Halt
Australia's PharmAust eyes worst day in over 10 mths on discounted placement
Brief: Pharmaust Raises A$2.5M Via Placement
Brief: Pharmaust Ltd Seeks Trading Halt
Brief: Pharmaust Ltd Commenced Search For A New Australian-Based Chief Executive Officer
Australia's PharmAust gains on positive result for its motor neurone disease drug
Pharmaust jumps on promising results from motor neurone disease drug trial
Brief: Pharmaust Says To Undertake Phase 2 Study In Covid-19 Rather Than A Phase 1 Study
Australia Stock Exchange release from PHARMAUST : MPL manufactured and tableting commenced
Australia Stock Exchange release from PHARMAUST : PRE_NR Ends: 08:31:00
Australia Stock Exchange release from PHARMAUST : Preliminary MPL antiviral leukaemia preclinical WEHI results
Australia Stock Exchange release from PHARMAUST : PRE_NR Ends: 11:24:58
Australia Stock Exchange release from PHARMAUST : Key Appointment to Progress MPL COVID-19 Clinical Trial
Australia Stock Exchange release from PHARMAUST : PRE_NR Ends: 08:15:28